1. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs 
	Haslam et al., JAMA Netw. Open, 2019; 2(5):e192535.
2. Precision medicine using microbiota 
	Jobin, Science, 2018; 359(6371):32-34
3. The microbiome, cancer, and cancer therapy
	Helmink et al., Nature  Medicine, 2019; 25(3):377-388
4. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
	Fluckiger, …, Zitvogel et al., Science (2020); 369(6506):936–942
5. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets
	10.1038/nbt.3988 . https://doi.org/10.1038/nbt.3988
6. Secreted NF-κB suppressive microbial metabolites modulate gut inflammation
	 Giri et al., Cell Reports, 2022;  39(2):11064
7. Mining the microbiota for microbial and metabolite-based immunotherapies
	 Skelly et al., Nature Reviews Immunology, 2019; 19(5), 305-323.
8. Tanoue et al., Nature, 2019;  565(7741):600-605
9. Powell, K. (2020). Technology Feature| Can patients' gut microbes help fight cancer?. Science, 370(6519), 997-1000
10. Skelly et al., Nature Reviews Immunology, 2019; 19(5), 305-323.